Testosterone deficiency syndrome and prostate cancer: illustrative annotations for a debate

Authors

  • Alvaro Morales Centre for Applied Urological Research and the Department of Urology, Queen’s University and General Hospital, Kingston, ON
  • Angela Black Centre for Applied Urological Research and the Department of Urology, Queen’s University and General Hospital, Kingston, ON

DOI:

https://doi.org/10.5489/cuaj.528

Abstract

As illustrated in this issue of the CUAJ,1 the use of testosterone
in elderly men diagnosed with testosterone deficiency syndrome
(TDS), or hypogonadism, remains controversial. Perhaps the most
contentious point refers to the effect of supplemental testosterone on
prostate health. In the last few years, small studies appear to indicate
that in men treated successfully for prostate cancer and TDS, testosterone
treatment is warranted, usually successful and largely free of serious
adverse effects.2,3 To complement some of the points raised, we present
a case that typifies the situation and strengthens some of the opinions
expressed in the Point / Counterpoint section of this issue.

Downloads

Download data is not yet available.

Author Biographies

Alvaro Morales, Centre for Applied Urological Research and the Department of Urology, Queen’s University and General Hospital, Kingston, ON

Angela Black, Centre for Applied Urological Research and the Department of Urology, Queen’s University and General Hospital, Kingston, ON

Downloads

How to Cite

Morales, A., & Black, A. (2013). Testosterone deficiency syndrome and prostate cancer: illustrative annotations for a debate. Canadian Urological Association Journal, 2(1), 52–4. https://doi.org/10.5489/cuaj.528

Issue

Vol. 2 No. 1 (2008): CUAJ February

Section

Case Report

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.